Abstract
BackgroundOsteoprotegerin (OPG) is a soluble decoy receptor which blocks osteoclast differentiation and activation by neutralizing the receptor activator of NF-κB ligand (RANKL). The balance between RANKL, which stimulates osteoclastogenesis and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
